Incorporated in December 2020, Stingray Bio Ltd operates from Hauxton House, Mill Scitech Park, Cambridge. Its registered SIC code 72110 places it squarely in research and experimental development on biotechnology. As a young biotech enterprise in the Cambridge region, it is likely involved in early-stage research, possibly spanning drug discovery, diagnostics, or therapeutics, though specific projects have not been disclosed. The company holds a Skilled Worker sponsor licence with a Worker rating, so it is permitted to employ overseas nationals in skilled roles. This licence, together with its recent incorporation, strongly suggests the company is building its research capacity and may be recruiting internationally. The Mill Scitech Park location places it within a dense cluster of life sciences companies, academic collaborators, and specialized service providers, which is typical for small biotech firms. No public records indicate the size of the workforce, but the nature of the sector and the company's age imply a small team, likely under a few dozen employees. Stingray Bio has not published details about its technology platform, funding status, or commercial partnerships, so those aspects remain unknown.

Incorporated in December 2020, Stingray Bio Ltd operates from Hauxton House, Mill Scitech Park, Cambridge. Its registered SIC code 72110 places it squarely in research and experimental development on biotechnology. As a young biotech enterprise in the Cambridge region, it is likely involved in early-stage research, possibly spanning drug discovery, diagnostics, or therapeutics, though specific projects have not been disclosed. The company holds a Skilled Worker sponsor licence with a Worker rating, so it is permitted to employ overseas nationals in skilled roles. This licence, together with its recent incorporation, strongly suggests the company is building its research capacity and may be recruiting internationally. The Mill Scitech Park location places it within a dense cluster of life sciences companies, academic collaborators, and specialized service providers, which is typical for small biotech firms. No public records indicate the size of the workforce, but the nature of the sector and the company's age imply a small team, likely under a few dozen employees. Stingray Bio has not published details about its technology platform, funding status, or commercial partnerships, so those aspects remain unknown.